Notably, melatonin induced a marked reduction in proliferation of p53 wild-type NSCLC cells (Fig. 6F) while the combination of P5091 and melatonin elicited strong growth inhibition of p53-deficient NSCLC cells (Fig. 6G). The gene discussed is TP53; the disease is non-small cell lung carcinoma.